热门资讯> 正文
AtriCure Says it Has Received Expanded Indication for AtriClip in Europe
2024-08-22 21:29
09:29 AM EDT, 08/22/2024 (MT Newswires) -- AtriCure (ATRC) said Thursday it has received an expanded indication in CE-marked countries in Europe for the AtriClip device.
The product can now be used in patients at "high risk" of thromboembolism for whom left atrial appendage exclusion is warranted, the company said.
The AtriClip devices are used during cardiac surgery to reduce the risk of stroke by isolating and excluding the left atrial appendage, a primary source of blood clots in atrial fibrillation patients.
Price: 23.98, Change: -0.01, Percent Change: -0.04
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
